The controversy surrounding vaccination of young people against COVID‐19
| Autor: | Sergio Verd, Marisa Fernandez-Bernabeu, Esther Cardo |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Adolescent Coronavirus disease 2019 (COVID-19) SARS-CoV-2 business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Vaccination MEDLINE COVID-19 General Medicine Reader's Forum Family medicine Pediatrics Perinatology and Child Health medicine Humans Christian ministry business |
| Zdroj: | Acta Paediatrica (Oslo, Norway : 1992) |
| ISSN: | 1651-2227 0803-5253 |
| Popis: | We agree with the view already expressed by Glikman et al.1 that Israel has gained world leadership in technology and capacity of COVID-19 vaccination. However, in these days of mandates on full vaccination of children against COVID-19, a sustained communication effort is required to reassert this leading position. Glikman et al. report that on May 2021, the CDC and the Israeli Ministry of Health (IMOH) concluded that the potential benefits of COVID-19 vaccination outweigh (…) the possible risk of peri-myocarditis. Subsequently, on 2 June 2021, the IMOH approved the vaccine for children and adolescents 12-15 years old. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text